NATIONAL FOOTBALL LEAGUE PLAYERS ASSOC. v. National Football League

598 F. Supp. 2d 971, 2008 U.S. Dist. LEXIS 103163, 2008 WL 5191442
CourtDistrict Court, D. Minnesota
DecidedDecember 11, 2008
DocketCivil 08-6254 (PAM/JJG), 08-6255 (PAM/JJG)
StatusPublished
Cited by4 cases

This text of 598 F. Supp. 2d 971 (NATIONAL FOOTBALL LEAGUE PLAYERS ASSOC. v. National Football League) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NATIONAL FOOTBALL LEAGUE PLAYERS ASSOC. v. National Football League, 598 F. Supp. 2d 971, 2008 U.S. Dist. LEXIS 103163, 2008 WL 5191442 (mnd 2008).

Opinion

MEMORANDUM AND ORDER

PAUL A. MAGNUSON, District Judge.

This matter is before the Court on the Motion for Preliminary Injunction filed in case 08-6254 by the National Football League Players Association, and Defendants’ Motion to Dissolve the temporary restraining order (“TRO”) in case 08-6255. On December 5, 2008, after hearing the oral arguments of the parties, the Court temporarily granted the Motion for Preliminary Injunction and denied the Motion to Vacate, finding that the complexity of the case demanded preservation of the status quo to allow the Court to give full consideration to the issues involved. The Court has now carefully reviewed the parties’ submissions. Based on those submissions and the arguments of counsel, the Court determines that extension of the preliminary injunction is warranted.

*975 BACKGROUND

A. Facts

On Tuesday, December 2, 2008, a Hearing Officer upheld two labor arbitration awards that suspended for the remaining four weeks of the season five players in the National Football League (“NFL”): Kevin Williams and Pat Williams of the Minnesota Vikings and Charles Grant, Deuce McAllister, and Will Smith of the New Orleans Saints. The players all tested positive for the diuretic bumetanide and were suspended pursuant to the NFL’s Policy on Anabolic Steroids and Related Substances (the “Policy”). The Policy lists bumetanide as a banned substance and provides that “[t]he first time a player violates this Policy by testing positive [for a banned substance] ... he will be suspended without pay for a minimum of four regular and/or postseason games.” (Jacobson Decl. Ex. A (hereinafter “Policy”) at ¶ 6 (emphasis in original).) The Policy imposes strict liability on players — in other words, “a positive test result will not be excused because a player was unaware that he was taking a [banned substance].” (Id. at ¶ 3.E.)

Defendant Dr. John Lombardo is the “Independent Administrator” of the Policy. (Id. at Appx. B.) Defendant Dr. Bryan Finkle is the “Consulting Toxicologist.” (Id.) As the Independent Administrator, Lombardo is solely responsible for administering the testing regimen, analyzing test results (in consultation with Finkle), and certifying violations of the Policy. (Id. at ¶ 2.) In addition, Lombardo is responsible for consulting with players and team physicians and for developing educational materials. (Id.) The Policy directs players with questions about a specific supplement to call either Lombardo or the NFL Supplement Hotline (the “Hotline”). (Id. at ¶ 3.E.)

The facts show that the players tested positive after they took an over-the-counter weight-loss supplement called Star-Caps. Bumetanide is not listed on the label as an ingredient in StarCaps, but there is no dispute that StarCaps contains bumetanide. The National Football League Players Association (“NFLPA” or “union”) contends, and the NFL 1 does not dispute, that the players unknowingly ingested bumetanide. Bumetanide is banned under the Policy because it can mask the presence of steroids, but there is no allegation that the players’ use of Star-Caps was intended to mask steroid use. There is also no allegation that the players took any anabolic steroid. The NFLPA contends that Lombardo, Finkle, and Defendant Adolpho Birch (the NFL’s Vice President of Law and Labor Policy) knew as early as 2006 that StarCaps contained bumetanide but deliberately failed to communicate this information to players or the union.

The NFL does not deny that Lombardo, Finkle, and Birch knew that StarCaps contained bumetanide. Indeed, the NFL concedes that Lombardo and Finkle directed a laboratory to perform tests on StarCaps and that those tests determined that Star-Caps contained bumetanide. The results of the tests were published in the November/December 2007 Journal of Analytical Toxicology. (Jacobson Decl. Ex. C at 5.) Despite this knowledge, the NFL contends that they had no duty to warn players specifically about StarCaps, because the Policy provides that players are responsible for what is in their own bodies, and also warns players about using over-the-counter supplements. (See Policy at ¶ 3.E and Appx. F.) Indeed, the Policy notes that over-the-counter supplements may not *976 “contain the ingredients listed on the packaging.” (Id. Appx. F.)

After the players were notified about their positive tests, each requested a hearing under the Policy. (Id. at ¶ 10.) The Policy provides that “the Commissioner or his designee will preside as Hearing Officer.” (Id.) The Commissioner designated Jeffrey Pash, the NFL’s chief legal officer, to act as the Hearing Officer. Mr. Pash held two hearings, one on the Williamses’ appeal and one on the appeal of Grant, McAllister, and Smith. As noted by the substantively identical arbitration awards Mr. Pash issued in each matter, the players argued that their violations of the Policy “should be excused because the NFL and Dr. Lombardo were aware that Star-Caps contained an undisclosed banned substance, bumetanide, but did not specifically advise NFL players of this fact.” (Jacobson Decl. Ex. C at 7.) Although the players did not contend that either the NFL or Lombardo had a duty to test specific supplements for banned substances, they argued that “where, as here, the testing process leads to specific information about a specific product, ... the league and Dr. Lombardo have a duty to inform NFL players____” (Id.)

The testimony at the hearing showed that none of the players contacted Lombardo about StarCaps, although at least one player did ask a team trainer to call the Hotline to ask about StarCaps. According to the player, the Hotline told the trainer that StarCaps did not contain any banned substances. Others testified that the Hotline did not offer information about specific supplements, but rather warned callers to avoid supplements altogether. In addition, Lombardo himself testified that, had any player asked him specifically about StarCaps, he would “strongly urge [the player] not to take the product” because “weight reduction products historically have either a diuretic or a stimulant.” (Id. at 6 (quoting Tr. at 100, 105-106).) Notably, Lombardo did not testify that he would have told the player that StarCaps contained a banned substance.

Ultimately, Mr. Pash upheld the players’ suspensions:

The rule puts the burden on players to be responsible and accountable for what is in their bodies. It avoids complex issues of intent and ensures that all players will be treated equally under the Policy. It establishes a simple and straightforward — if admittedly inflexible-rule to guide player conduct and administration of the Policy. Based on this record, there is no question that each of these players have [sic] heard and understood those warnings and know that they are responsible for what is in their bodies.

(Id.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
598 F. Supp. 2d 971, 2008 U.S. Dist. LEXIS 103163, 2008 WL 5191442, Counsel Stack Legal Research, https://law.counselstack.com/opinion/national-football-league-players-assoc-v-national-football-league-mnd-2008.